IP Library Granted Patent US 9,844,615
Granted Patent B2
US 9,844,615 · App. 14/924,179 · Granted Dec 19, 2017

System for extended storage of red blood cells and methods of use

Inventors: Tatsuro Yoshida (West Newton, MA); Paul Vernucci (Billerica, MA)
Assignee: New Health Sciences, Inc.
A61M1/0209A01N1/021A01N1/0226A01N1/0263A01N1/0294A61M1/0231A61M1/0272B01D19/0031A61M2202/0208A61M2202/0225
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,844,615
App. No.
14/924,179
Granted
Dec 19, 2017
Kind
B2
Abstract

A system and methodology for the preservation of red blood cells is described in which red blood cells are oxygen or oxygen and carbon dioxide depleted, treated and are stored in an anaerobic environment to optimize preparation for transfusion. More particularly, a system and method for extended storage of red blood cells from collection to transfusion that optimizes red blood cells prior to transfusion is described.

Claims (29)

1. A method for preparing whole blood for transfusion comprising:

obtaining whole blood;

depleting oxygen and carbon dioxide from said whole blood prior to storage to prepare oxygen and carbon dioxide depleted whole blood;

storing said oxygen and carbon dioxide depleted whole blood in a anaerobic storage bag comprising an outer bag having a barrier film that is impermeable to oxygen and carbon dioxide, an inner bag in contact with said whole blood, and an oxygen and carbon dioxide sorbent disposed between said inner bag and said outer bag.

2. The method of claim 1 , further comprising oxygenating said stored oxygen and carbon dioxide depleted whole blood.

3. The method of claim 1 , further comprising leukoreducing said whole blood prior to said depleting.

4. The method of claim 1 , wherein said inner bag comprises polyvinyl chloride (PVC).

5. The method of claim 4 , wherein said inner bag comprises di(2-ethylhexyl) phthalate (DEHP)-plasticized PVC.

6. The method of claim 1 , further comprising inactivating pathogens before storage of said oxygen and carbon dioxide depleted whole blood.

7. The method of claim 6 , wherein said inactivating pathogens comprises riboflavin and light therapy.

8. The method of claim 1 , wherein said depleting oxygen and carbon dioxide comprises passing said whole blood through a combined leukoreduction and oxygen and carbon dioxide depletion device.

9. The method of claim 8 , wherein said depleting oxygen and carbon dioxide from said whole blood comprises passing said whole blood through a device having a disposable housing, an inlet port, an outlet port, one or more gas permeable membranes adapted to receiving and conveying whole blood, an oxygen sorbent and a carbon dioxide sorbent to form oxygen and carbon dioxide depleted whole blood.

10. The method of claim 9 , wherein said oxygen sorbent and said carbon dioxide sorbent of said anaerobic storage bag, of said combined leukoreduction and oxygen and carbon dioxide depletion device, or of said anaerobic storage bag and said combined leukoreduction and oxygen and carbon dioxide depletion device, are a combined oxygen and carbon dioxide sorbent.

11. The method of claim 1 , further comprising adding an additive solution to said whole blood to form a suspension of whole blood.

12. The method of claim 11 , wherein said additive solution comprises AS-1, AS-3, AS-5, SAGM, PAGG-SM, PAGG-GM, MAP, SOLX, ESOL, EAS61, OFAS1, OFAS3, or any combinations thereof.

13. The method of claim 1 , wherein said anaerobic storage bag having depleted whole blood is stored under refrigeration.

14. The method of claim 13 , wherein said storage temperature is from 1 to 6° C.

15. The method of claim 1 , further comprising one or more steps selected from the group consisting of:

irradiating said whole blood or said oxygen and carbon dioxide depleted whole blood;

inactivating pathogens in said whole blood or said oxygen and carbon dioxide depleted whole blood; and

editing said whole blood or said oxygen and carbon dioxide depleted whole blood.

16. A kit for the collection and storage of whole blood comprising

a phlebotomy needle;

a collection bag having an anticoagulant solution;

a depletion device comprising a housing, a plurality of membranes permeable to both oxygen and carbon dioxide and are adapted to receiving and conveying whole blood extending within the housing from an entrance to an exit thereof;

an amount of both an oxygen sorbent and carbon dioxide sorbent packed within the housing and contiguous to said plurality of membranes; and

a storage bag comprising an outer bag having a barrier film, an inner bag in contact with said whole blood, and a sorbent disposed between said inner bag and said outer bag.

17. The kit of claim 16 , further comprising a leukoreduction device.

18. The kit of claim 17 , wherein said leukoreduction device is a combined leukoreduction and depletion device.

Assignments (2)
CHANGE OF NAME Recorded Jun 8, 2020
From: NEW HEALTH SCIENCES, INC.
To: HEMANEXT INC.
Reel/Frame 052874/0456 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2015
From: YOSHIDA, TATSURO; VERNUCCI, PAUL
To: NEW HEALTH SCIENCES, INC.
Reel/Frame 036947/0398 →
Continuity (11)
Continuation 13541554 · Jul 3, 2012
Continuation In Part 12901350 · Oct 8, 2010
Continuation In Part 13115532 · May 25, 2011
Continuation 12903057 · Oct 12, 2010
Continuation In Part 13289722 · Nov 4, 2011
Provisional Application 61504640 · Jul 5, 2011
Provisional Application 61504644 · Jul 5, 2011
Provisional Application 61331693 · May 5, 2010
Provisional Application 61250661 · Oct 12, 2009
Provisional Application 61410684 · Nov 5, 2010
Related Publication 20160045650A1 · Feb 18, 2016